You are here:
NICE
NICE Guidance
Conditions and diseases
Cancer
Metastases
Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma
Technology appraisal guidance
Reference number:
TA169
Published:
25 March 2009
Guidance
Tools and resources
Information for the public
Evidence
History
Research recommendations coming out of this guidance
There are no research recommendations for TA169